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ABSTRACT 
 
VASCULAR REACTIVITY IN IMMATURE ARTERIALIZED CAPILLARIES 
 
Sara Hellstrom 
 
Peripheral arterial occlusive disease (PAOD) is a globally prevalent 
cardiovascular disease in which atherosclerotic plaques narrow arterial lumen diameters 
and restrict blood flow to down stream tissues. The impact of these occlusions can be 
mitigated by collateral vessels that connect parallel arterial branches and act as natural 
bypasses to maintain perfusion. Some patients with PAOD may not have robust collateral 
networks to accommodate ischemic tissues in the event of an occlusion and, therefore, 
may be more susceptible to hypoxia and tissue necrosis. In animal models that lack 
collateral arterioles, capillaries can arterialize and form functional collaterals; however, in 
the early stages of development, they do not exhibit functional vasodilation in response to 
muscle contraction. We explored the mechanism of impaired functional vasodilation in 
arterialized capillaries by testing endothelial-dependent vasodilation (acetylcholine), 
endothelial-independent vasodilation (sodium nitroprusside), and endothelial-independent 
vasoconstriction (norepinephrine). First, we performed pilot studies to generate dose-
response curves to each of these agents in spinotrapezius arterioles. The optimal 
concentration that produced the most robust vascular responses was 10-5 M for all three 
agents. In the following study, the spinotrapezius feed artery was ligated in Balb/C mice, 
a strain that lacks native collaterals, to stimulate the development of arterialized 
capillaries and determine their vascular reactivity. Although vasodilation and 
vasoconstriction in arterialized capillaries seven days post-surgery were impaired 
compared to terminal arterioles of similar size in unoperated animals, the vessel diameter 
changes were still significant. The comparable impairment in both endothelial-dependent 
and endothelial-independent vasodilation indicates that vascular smooth muscle cells are 
still developing, rearranging, or both, and are not yet fully capable of regulating diameter 
in immature arterialized capillaries. Identifying factors that improve the functionality of 
smooth muscle cells in the arterialized capillaries may be applied to improve patient 
prognosis during ischemic events in vasculature lacking pre-existing collaterals. 
 
Keywords: arteriogenesis, arterialization, ischemia, peripheral arterial occlusive disease, 
vasodilation, spinotrapezius  
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I. INTRODUCTION 
Clinical Relevance  
Chronic ischemia—a restriction of bloody supply to tissue—impairs arterial 
function in the microcirculation [2]. Specifically, chronic ischemia due to peripheral 
arterial occlusive disease (PAOD) impairs vasodilation in the limb skeletal muscles 
(Figure 1) [11]. In 2012, approximately 8 million Americans had PAOD, a number that 
 
Figure 1. Atherosclerosis in PAOD, where narrowed and hardened arteries 
reduce blood flow to limbs [3]. 
has been increasing for the past decade. The most common symptom of PAOD is 
intermittent claudication, or hypoxic pain during locomotion, which is amplified during 
exercise [3]. The ischemic tissues do not receive sufficient oxygen or nutrients, and a 
chemical imbalance leads to cramping and discomfort [3]. In PAOD patients, this 
discomfort is extreme and prevents any further immediate exercise. 
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Once PAOD has been diagnosed, initial treatments include lifestyle modifications 
such as cessation of smoking, integration of regular physical activity, and adjustments in 
diet. If lifestyle modifications are ineffective, pharmacotherapy with anti-thrombogenic 
medications such as aspirin can be administered to prevent thrombus formation on the 
atherosclerotic plaque(s). In severe cases, bypass surgery and percutaneous interventions, 
including angioplasty, can be used to restore blood flow downstream of the 
atherosclerotic plaque as a last resort [3,7]. Unfortunately, not all patients are candidates 
for surgery, percutaneous interventions may fail due to restenosis, and current 
pharmacotherapy medications often have undesirable side effects. Therefore, developing 
alternative methods to restore blood flow to ischemic zones is necessary to improve 
PAOD-patient prognosis and treatment.  
Previous Work 
Stimulating the development of collateral networks is one potential alternative for 
restoring blood flow in patients that are not candidates for bypass or percutaneous 
interventions. Collateral networks improve patient prognosis by redirecting blood flow in 
the event of arterial occlusion. With a collateral, or a vessel connecting two parallel 
arterial segments in series, nutrient-rich blood has an alternative path to reach 
downstream tissues that would, otherwise, become anoxic [26]. When blood flow is 
redirected and shear stresses increase due to the occlusion, collateral vessels enlarge via 
arteriogenesis, in which vessels outwardly remodel and incorporate a thicker layer of 
smooth muscle cells [9]. Historically, arteriogenesis was only thought to be possible in 
pre-existing collateral arterioles, and not all animal strains have robust collateral 
networks to support arteriogenesis by this historical definition. The variation in collateral 
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density between strains of mice can be extrapolated to humans such that some patients 
may be genetically more susceptible to ischemia.  
Two strains of mice that exemplify differences in collateral networks are C57BL6 
and Balb/C. C57 is a commonly used strain of mouse in research [25] and has a high 
density of collaterals, while the Balb/C strain has a lower or nonexistent density of 
collaterals, depending on the tissue. In Balb/C mice, however, upstream arterial occlusion 
induces outward remodeling on a smaller scale, involving the arterialization of so-called 
“collateral capillaries” that anatomically connect two vascular trees. Although they 
typically have high resistances that prevent their function as true collaterals, these 
capillaries can recruit smooth muscle cells and develop into arterioles [9,30]. The newly 
developed arterialized capillaries act as collaterals to reperfuse ischemic tissues; 
however, these new vessels are functionally impaired in their early stages [6]. 
Specifically, functional vasodilation is absent seven days after occlusion of 
upstream arteries in the spinotrapezius muscle of murine models [6]. Interestingly, at 21 
days post-ligation, these arterialized capillaries regained functionality and demonstrated 
normal vasodilation following muscle contraction, even trending towards a greater than 
normal response. Regaining vasodilatory capabilities is important because, when it is 
impaired, these arterialized capillaries fail to meet the demands of downstream tissue 
when metabolism increases, for instance, during locomotion or exercise [4].  
 Because the impairment is temporary, the initial dysfunction may be attributed to 
immaturity of the vascular smooth muscle cells within the outward remodeling phase 
[20]. The cause of early impairment in vessel function is unknown: whether it relates to 
smooth muscle cell function, endothelial cell function, or both. Understanding 
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impairment in microcirculation, specifically in new collateral vessels resulting from 
occlusions of PAOD, could provide knowledge to support the development of more 
efficacious therapies to mediate and resolve one of the most prevalent health issues in the 
world today.  
Purpose of Current Study 
The purpose of this study was to determine the mechanism of impaired 
vasodilation in immature arterialized capillaries. Specifically, we tested the hypothesis 
that impaired functional vasodilation can be explained by vascular smooth muscle cell 
(VSMC) dysfunction. To test this hypothesis, arterialized capillaries were exposed to 
acetylcholine (ACh), sodium nitroprusside (SNP), and norepinephrine (NE) via 
superfusion of a physiological salt solution seven days post-ligation. These agents 
allowed us to evaluate endothelial-dependent vasodilation via acetylcholine and smooth 
muscle-dependent vasodilation via sodium nitroprusside. Endothelial-independent 
vasoconstriction via norepinephrine was also evaluated to confirm that the VSMCs were 
contractile.  
 Acetylcholine (ACh) is a neurotransmitter that leads to vasodilation by diffusing 
from synaptic clefts into endothelial cells and activating a G-protein coupled receptor 
(GPCR) cascade that stimulates endothelial nitric oxide synthase (eNOS) to then produce 
NO [14]. NO binds to smooth muscle cell guanylyl cyclase receptors, which increases 
cyclic guanosine monophosphate (cGMP) production, thereby activating protein kinase G 
(PKG). PKG closes calcium channels, opens potassium channels, and phosphorylates 
myosin light chain kinase, decreasing intracellular calcium levels, inducing 
hyperpolarization, and inhibiting contraction, respectively. This reduces cross-bridge 
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cycling and relaxes the muscle to ultimately achieve vasodilation [14]. Sodium 
nitroprusside (SNP) triggers vasodilation by breaking down into nitric oxide (NO) and 
other components, relaxing the smooth muscle directly (Figure 2).  
 
Figure 2. Cell signaling for smooth muscle relaxation [24]. Regardless of the initial 
stimulus, vascular smooth muscle ultimately vasodilates in response to NO. 
 
Because SNP bypasses the endothelial activation of NO, SNP is considered a smooth 
muscle-dependent vasodilator, and ACh is considered an endothelial-dependent 
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vasodilator. Norepinephrine is a neurotransmitter that activates alpha-1 adrenergic 
receptors on the smooth muscle cells to increase intracellular calcium, increase cross-
bridge cycling, and constrict the vessel (Figure 3) [14].  
 
Figure 3. Cell signaling for smooth muscle contraction. Increasing intracellular 
calcium within the smooth muscle allows for increased cross-bridge cycling. 
 
The adrenergic receptors activate phospholipase C to break phosphatidylinositol 4,5-
bisphosphate (PIP2) down into inositol trisphosphate (IP3) and diacylglycerol (DAG). 
DAG and IP3 increase intracellular calcium directly and by activating phosphokinase C, 
respectively. 
We exposed murine spinotrapezius muscles to each of the vasoactive agents to 
determine which cell type impairs vasodilation in the arterialized capillaries. Equal 
responses from both the terminal arterioles in the sham side and arterialized capillaries in 
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the ligated side would demonstrate a lack of dysfunction or damage in the corresponding 
vessel; however, failure to respond or difficulty responding implies that either one or both 
cell types are impaired. We hypothesize that the smooth muscle is immature so that we 
expect equal relative impairment in response to ACh and SNP on the ligated side. Once 
the contributors to vascular impairment are specified, we may be able to identify factors 
to quicken and support the development and maturation of arterialized capillaries. Less 
time with dysfunctional collaterals will reduce tissue susceptibility to ischemia, as 
perfusion will more effectively meet tissue metabolic demand. As found in different 
strains of mice, there may be a distinct variation in human vasculature that affects our 
aptitude to respond to ischemia. Individuals with robust collateral networks are better 
equipped to redirect blood flow around an occlusion and avoid strokes and myocardial 
infarctions [30]. By facilitating efficient development of these collateral networks, we 
may improve prognoses of patients with less advantageous vasculature to cope with 
diseases like PAOD.  
Specific Aims 
Specific Aim 1: To assess the reactivity of terminal arterioles in unoperated mice 
with a normal density of pre-existing collaterals to determine optimum reagent 
concentrations and to anticipate expected responses.  
Specific Aim 2: To test the hypothesis that smooth muscle-dependent vasodilation 
is impaired in arterialized capillaries at day-7 following spinotrapezius feed artery 
ligation.  
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II. METHODS 
Animal Care and Housing 
Male swiss webster and Balb/C mice were housed in microisolator cages within 
temperature controlled rooms in the University Vivarium for the duration of the 
experiment where 12 hour light and dark cycles were maintained. All mice were provided 
with food, water, bedding, a plastic “mouse house,” and a plastic tube. Balb/C mice had 
no more than three other cage-mates. These mice were cared for and utilized under the 
guidelines specified by the Cal Poly State University SLO Institutional Animal Care and 
Use Committee.  
Vascular Reactivity with Intravital Microscopy – Dose Response 
All equipment that contacted the solutions was rinsed at the end of every 
procedure. This equipment included two bubblers, two 60 mL syringes, a flow meter, 
small sections of 1/8” tubing, luer connections, and tips. Physiological salt solution (PSS) 
was prepared the day of each procedure from stock solution with 131.9 mM NaCl, 
4.7 mM KCl, 1.17 mM MgSO4, 2 mM CaCa2, and 18 mM NaHCO3 mixed in a 1 L  
volumetric flask with 1 L of ohmic water. The flask was heated and deoxygenated in a 
water bath set to 50ºC with 5% CO2-95% N2 bubbled into it. pH was kept at ~7.4 and 
checked with a pH meter. The solution was manually transferred to heated 60 mL 
syringes as needed to maintain an effluent flow rate of ~2 mL·min-1 and temperature of 
~35ºC. ACh, SNP, and NE were diluted from 10-3 Molar stock solutions to 10-5 Molar.  
Each mouse was initially anesthetized using 5% isoflurane in oxygen in an 
induction chamber. The mice were, then, transferred to a preparation bench with 
isoflurane reduced to ~1-3% and maintained at ~3 l·min-1 via nose cone throughout the 
preparations and procedure. The hair on the anterior dorsal aspect of each mouse was 
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removed with clippers and depilatory cream. Following skin preparations, each mouse 
was transferred to a heat pad in the prone position. 
Internal temperatures of each anesthetized mouse were kept at 35ºC via heat pad 
and rectal thermistor. Following an initial skin incision at the caudal end of the 
spinotrapezius, the skin was retracted and connective tissue removed to expose the 
muscle. The exposed tissue was continually irrigated with PSS from the heated syringes, 
and any area not irrigated by the PSS was covered with plastic wrap to prevent 
desiccation and to minimize atmospheric oxygen exchange.  
Terminal arterioles in the spinotrapezius were identified on the intravital 
microscope and video was captured of the baseline diameters of the terminal arterioles 
after a 30 minute stabilization period. Vasodilator and vasoconstrictor agents were 
administered via micropipettes and a graduated cylinder to the area through the syringe 
and tubing at 10-7, 10-6, 10-5, and 10-4 Molar concentrations, in that order. After each 
vasoactive agent was added, a 5-minute waiting period was utilized to allow the vessels 
to equilibrate before recording the videos in the final minute of each respective waiting 
period. At the end of the experiment, the mouse was euthanized using cervical 
dislocation. 
Spinotrapezius Lateral Feed Artery Ligation 
To stimulate the arterialization of capillaries, the lateral spinotrapezius feed artery 
was ligated. Mice were anesthetized and hair was removed as described above. 
Buprenorphine analgesic (0.075 mg·kg-1) was subcutaneously administered prior to the 
surgery. To prevent corneal desiccation, veterinary ophthalmic ointment was applied to 
the eyes of the mice. A skin incision was made above the cranial, lateral edge of the 
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spinotrapezius where it meets with the fat pad. Phosphate buffered saline (PBS) was 
frequently applied to prevent desiccation. The fat pad cranial and superficial to the 
spinotrapezius muscle was blunt dissected to expose the lateral edge. Between the fat pad 
that lies deep to the spinotrapezius and the lateral edge of the muscle; the spinotrapezius 
artery/vein pair was identified and the artery was isolated and ligated with free strands of 
6-0 silk suture. The skin incision was closed with 7-0 polypropylene suture and analgesic 
was subcutaneously administered immediately after the surgery to minimize discomfort 
as the animal recovered. For two days following the ligation, the mice received oral 
buprenorphine (0.01 mg/mL) mixed in with the water. 
Vascular Reactivity with Intravital Microscopy 
7 days following each ligation surgery the spinotrapezius muscle was re-exposed. 
The same superfusion protocol was followed, as described above, but each vasodilator 
agent was only administered to the area once at 10-5 concentrations. Terminal arterioles 
were analyzed on the sham side and arterialized capillaries were analyzed on the ligated 
side. 
Imaging and Statistical Analysis 
The images/videos were analyzed using AVA software to compare diameters at 
the respective time points and concentrations via percent differences, standard deviation, 
and standard error. Significance between diameters and percent changes before and after 
reactivity and between the sham and ligated sides was rated against a 0.05 p-value using 
paired and homoscedastic statistical t-tests. 
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III. RESULTS 
Average dosage response curves were calculated for each of the three vasoactive 
agents in swiss webster strain mice to determine the concentration necessary to elicit a 
maximal response: a maximum vasodilation in response to acetylcholine (ACh) and 
sodium nitroprusside (SNP), and a maximum vasoconstriction in response to 
norepinephrine (NE) (Figure 3).  
 
Figure 4. Superfusion dosage responses in terminal arterioles of unoperated 
animals. A) Diameter in microns of Swiss-Webster strain pre and post exposure to 10-
fold dilutions of ACh (n=7), SNP (n=9), and NE (n=5). B) Diameter in microns of Balb/C 
pre and post exposure to 10-fold dilutions of ACh and SNP (n=1). 
The diameter responses from both the Swiss-Webster strain (high density of collaterals) 
and the Balb/C strain (low density of collaterals) followed a sigmoid curve pattern. The 
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resting diameters and responses at each concentration are comparable between the strains. 
Vessels reached a maximal vasodilation or vasoconstriction at 10-5 molar concentration in 
response to each vasoactive agent. Only one dosage response was performed for the 
Balb/C strain so that statistics could not be evaluated between the Swiss-Webster and 
Balb/C diameters.  
We utilized 10-5 molar concentrations of each agent to elicit maximal vasodilation 
and vasoconstriction responses. To compare reactivity between arterialized capillaries 
and terminal arterioles of approximately the same size in unoperated muscles, vascular 
reactivity was assessed in the spinotrapezius muscles of mice with ligated and unligated 
(sham) feed arteries seven days post-surgery. The muscles were exposed to acetylcholine 
and sodium nitroprusside to observe vasodilation responses, and to norepinephrine to 
observe vasoconstriction responses. Vessel diameters were measured in terminal 
arterioles before and after ACh and SNP application; however, larger arterioles were 
measured following norepinephrine application in attempts to measure accurate diameters 
during vasoconstriction. Nearly all vessels on the unoperated sides constricted to a point 
at which luminal diameter was absent.  
ACh (endothelial-dependent) and SNP (endothelial-independent) both 
significantly increased vessel diameters in the terminal arterioles of the sham side and 
arterialized capillaries in the ligated side to roughly the same degree; however, the 
terminal arterioles dilated significantly more than did the arterialized capillaries (Figure 
5A,B). NE (endothelial-independent) significantly decreased vessel diameters in the 
sham and ligated sides; however, the terminal arterioles constricted significantly more 
than did the arterialized capillaries (Figure 5C).  
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Figure 5. Superfusion Day 7 - Terminal arterioles on sham and arterialized 
capillaries on ligated side. A) Diameters in microns pre and post exposure to 10-5 ACh 
(n=7). B) Diameters In microns pre and post exposure to 10-5 SNP (n=7). C) Diameters In 
microns pre and post exposure to 10-5 NE (n=6); * indicates p <= .05 using a paired 
students  t-test 
* 
* 
* 
* 
* 
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For the control arterioles, ACh induced a significant vasodilation from rest 8.0±0.8 µm 
vs. dilated 14.2±6.4 µm, SNP induced a significant vasodilation from rest 8.1±0.9 µm vs. 
dilated 16.4±2.9 µm, and NE induced a significant vasoconstriction from rest 14.9±9.4 
µm vs. dilated 0.0±0.0 µm. For the arterialized capillaries, ACh induced a significant 
vasodilation from rest 8.6±1.0 µm vs. dilated 10.5±1.7 µm, SNP induced a significant 
vasodilation from rest 9.0±1.1 µm vs. dilated 11.0±1.6 µm, and NE induced a 
vasoconstrictive trend from rest 9.2±1.2 µm to 8.2±1.0 µm.  
When comparing the percent changes in diameter between the sham and ligated 
sides after exposure to vasoactive agents, there were significant differences for each 
vasoactive agent. The two vasodilators, ACh and SNP, both increased the percent change 
diameter in the sham side significantly more than in the ligated side. The percent change 
induced by ACh on the sham vs. ligated side was 72.7±23.2% vs. 23.0±4.9%. The 
percent change induced by SNP on the sham vs. ligated side was 104.0±10.8% vs. 
23.2±5.5%. The vasoconstrictor, NE, significantly decreased the percent change in 
diameter in the sham as compared to the ligated side from -100.0±0.0% vs. -10.7±7.8% 
(Figure 6).  
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Figure 6. Relative vasoreactivity of the arterioles in the spinotrapezius. Percent 
changes between the sham and ligated sides in their respective responses to 10-5 M ACh 
and SNP in the terminal arterioles, and 10-5 M NE in the arterioles. P =< 0.05 for all 
vasoactive agents; n=4. 
 
SNP has a tendency to induce a greater vasodilation than ACh, though not 
significantly. Although the vasoactive agents cause significant changes in diameter to the 
arterialized capillaries, these changes are significantly less than those in terminal 
arterioles. 
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IV. DISCUSSION 
Collateral vessels can maintain perfusion in downstream tissues that would, 
otherwise, be ischemic in the event of a conduit artery occlusion. These collaterals 
respond to increased shear stress by outwardly remodeling and increase blood flow as a 
result of that process; however, collaterals can only outwardly remodel if they exist in the 
vasculature. The  arterialization of collateral capillaries in animals lacking pre-existing 
collateral arterioles can compensate enough to re-establish blood flow to an ischemic 
vascular tree [6,9]; however, to match blood flow with tissue demand in the reperfused 
areas, collaterals and/or arterialized capillaries need to be able to sufficiently vasodilate. 
Although the arterialized capillaries acquire smooth muscle cells within seven days 
following the spinotrapezius lateral feed artery ligation, functional vasodilation is absent 
at this time point [6,7,9]. In this study, we investigated possible causes of this impairment 
by observing endothelial cell-dependent and smooth muscle cell-dependent responses of 
arterialized capillaries seven days following the ligation of the spinotrapezius feed artery 
in mice lacking collaterals. We established a dosage response curve to identify the 
optimal concentrations to induce vasodilation and vasoconstriction. 
We also found that, although the arterialized capillaries did not respond to 
functional vasodilation at seven days post-ligation, they did significantly dilate or 
constrict to respective vasoactive agents. This discrepancy can be explained by the fact 
that these arterialized capillaries may not yet be a part of the conduction circuit within the 
vasculature. In normally functioning arterioles, local signals to dilate or constrict are 
conducted across the endothelial cells to change the diameter of upstream arterioles to 
effectively increase flow to the initial local stimulus [13]. Capillaries may not naturally 
be included in this circuit, or may not have the appropriate directionality to continue a 
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signal within the circuit, so it may take longer than seven days for them to fully 
arterialize and adapt to it. The vasoactive reagents were a more direct application to the 
endothelial and smooth muscle cells within the arterialized capillaries than the electrode 
stimulation of the muscles to instigate distinct diameter changes before the arterialized 
capillaries develop into part of the conduction circuit. 
Both endothelial cells and smooth muscle cells affect the remodeling process of 
arterioles. On a smaller scale, we hope to reveal more specifically how they contribute to 
the impaired vascular reactivity of the arterialized capillaries. At 7 days post-ligation, the 
arterialized capillaries demonstrated significantly less reactivity as compared to the 
terminal arterials of the non-ligated “sham” side. The arterialized capillaries dilated less 
in response to the vasodilators and constricted less in response to the vasoconstrictors. 
Because endothelial-independent vasodilation mechanisms were impaired to the same 
degree as endothelial-dependent mechanisms, we can associate at least part of the 
dysfunction with smooth muscle cells; however, we do not have sufficient evidence to 
associate causation with endothelial cell impairment. Potential causes of impairment 
include smooth muscle cell phenotype, mechanoadaptation, ECM remodeling, and lack 
of innervation. Mechanoadaptation and ECM remodeling are thought to eventually 
increase the reactivity of smooth muscles, at 28 days for example, but may initially 
inhibit proper smooth muscle function [6]. The decreased vasoconstriction may also be 
explained by a lack of innervation of the arterialized capillaries.  
Endothelial Cell Impairment 
Endothelial cell impairment may contribute to the impaired vasodilation and 
vasoconstriction in the arterialized capillaries; however, testing endothelial impairment 
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would require measuring the production of relaxing factors of the endothelial cells. 
Because this was not included in the study, we cannot explain the impairment by 
dysfunction of the endothelial cells.  
Smooth Muscle Cell Phenotype 
Mechanoadaptation entails the reorientation of vascular smooth muscle cells to 
accommodate a change in flow within a blood vessel. These mechanical changes are 
instigated by changes in shear stress, for example, perhaps, when blood supply is 
redirected as a result of an occlusion. In cases where pre-existing collateral vessels exist, 
blood flow will follow the path of least resistance and travel through the existing 
network, around the occlusion (Figure 7). The pre-existing collaterals experience 
increased shear stress following the ligation and consequent vasoactive autacoids are 
released. These autacoids include growth factors and vasodilators, like endothelium-
derived hyperpolarizing factor and prostaglandins, all of which contribute to the function 
and structure of vascular smooth muscle cells. [15] The smooth muscle cells have acute 
and chronic responses. During acute responses, smooth muscle cells utilize actin and 
myosin cross-bridge cycling to perform vasoconstriction; however, calcium sensitization 
and actin filament remodeling are also acute processes that can inhibit vasoconstriction 
responses. In a longer-term, chronic context, smooth muscle cells have been observed to 
physically rearrange. [15] 
Smooth muscle cells must be present for mechanoadaptation to occur. Because 
capillaries do not naturally have smooth muscle cells, they must develop and/or recruit 
the cells for mechanoadaptation to be a potential means of remodeling. 
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Figure 7. Blood flow and shear stress shift inducing collateral vessel development. 
[10] 
Vascular development revolves around the communication between endothelial and 
smooth muscle cells in regulating vascular formation, stabilization, remodeling, and 
function via factors such as hepatocyte growth factor (HGF) and angiopoietin-1 (Ang1) 
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[17]. Ang1, which regulates genes in ECs, is involved in recruiting the SMCs and 
maturing the vasculature, so that the success of the vascular development depends on 
paracrine communication with ECs. Vascular development also depends on endocrine 
factor processing [17].  
It is possible that the development and recruitment of the smooth muscle cells is 
contributing to the impairment because the cells are growing and/or adjusting. 
Periovascular cells can be recruited from the nearby arterioles or from the immediately 
surrounding tissue [22,28]. In any case, the cells will take time to arrange and, 
potentially, to further develop into fully functional cells. For example, if the fibroblasts 
are developing into SMCs, they may not yet have sufficient levels of actin and myosin to 
properly contract or dilate. Thus, the immaturity of the arterialized capillaries would 
impair vascular reactivity. 
Future work to expand on this research could entail ex-vivo examination of the 
arterialized capillaries to determine their precise cellular constituents. Observing vascular 
wall components of capillaries before, during, and after the remodeling process would 
provide a more clear depiction of how the cells are arranging and changing. Once we 
better understand the process, we may be able to stimulate or control it in vivo. 
Extracellular Matrix Remodeling 
 In addition to the rearrangement of smooth muscle cells, the extracellular matrix-
integrin-cytoskeletal axis is activated in response to long-term exposure to shear stress. In 
this axis, cell-cell and cell-extracellular matrix connections are strengthened to maintain 
vascular wall structural integrity; it is also dynamically involved in controlling 
vasoreactivity. [15] The responses in the ECM revolve around strengthening and 
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stiffening the vascular wall, a remodeling method thought to make constriction and/or 
dilation more efficient. [15]  
Outward remodeling has previously been observed in preexisting collaterals and 
vessels that already have the smooth muscle cells and ECM interactions to begin with. 
Smooth muscle cells do not naturally exist in capillaries, as vasoconstriction and 
vasodilation are not functions of that vessel type. When the spinotrapezius feed artery is 
ligated in a muscle containing few or no collaterals, blood flow redirects through 
collateral capillaries that connect arterial branches from other nearby feed vessels to 
accommodate the lack of perfusion. These collateral capillaries enlarge, and may remodel 
in a similar fashion to the preexisting collaterals. The results from this study point to 
early stages of smooth muscle cell maturation as a cause for the impaired vasoreactivity. 
The smooth muscle cells are likely immature in development and positioning so that they 
are not as receptive and/or responsive to vasoactive agents. 
The ability of capillaries to arterialize provides many possibilities for individuals 
lacking pre-existing collaterals to reperfuse ischemic tissues in the event of an arterial 
occlusion. These developed capillaries provide new bypass routes for blood to travel 
around the occlusion and reach areas downstream from the blockage. Further 
understanding of the mechanisms of this development may expose specific elements that 
are involved; these elements could be exogenously introduced to elicit or quicken the 
development process. The sooner blood returns to an ischemic area, the less time the 
tissues lack oxygen, nutrients, and the potential for necrosis. 
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Lack of Innervation 
Capillaries do not naturally have smooth muscle cells or innervation from the 
sympathetic nervous system, as dilation and constriction to regulate blood flow are not 
capillary functions. Though it can also cause dilation through β-adrenergic receptors, 
SNS stimulation typically causes vasoconstriction in skeletal muscle arterioles by 
activation of α-adrenergic receptors [27]. While norepinephrine (NE) is a very common 
constricting factor, cells may not be sensitive to it if they are not regularly exposed to the 
neurotransmitter. The insensitivity to NE could be due to decreased expression of the α-
adrenergic receptor, a complete lack of innervation, insufficiently organized actin and 
myosin preventing effective contractions.  
Limitations 
One limitation to this study is that dosage response curves were only performed 
on one replicate of the Balb/C strain. It is possible that the reactivity of the Balb/C strain 
varies enough from that of the Swiss-Webster strain that the concentrations used were not 
maximal, on average. The latter instance would have affected the data by resulting in 
smaller diameters during vasodilation and larger diameters during vasoconstriction, 
effectively reducing the percent change in diameter after exposure to each of the 
vasoactive agents. In future studies, dosage response curves could be calculated with 
more replicates of the Balb/C strain to confirm the optimal concentrations for NE, SNP, 
and ACh.  
Another limitation of this study is that other, natural stimuli are not necessarily 
accounted for. Sometimes, the vessels are dilated by other factors, such as muscle 
twitching, so that the baseline measurements may not reflect true resting values. When 
the muscles twitch, the local vessels dilate and vessels in other branches constrict, 
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varying the baseline to exaggerate either a difference or a similarity. The effects of 
muscle twitching are mitigated by continual irrigation with PSS and covering exposed 
tissue with plastic wrap when not in use. However, these measures do not prevent random 
muscle twitching and may not eliminate other stimuli. A more developed protocol for 
obtaining and monitoring baseline values may allow for more accurate measurements. 
For example, more effectively preventing muscle twitching with a different saline 
solution or cover, or minimizing the presence of other stimuli with longer equilibration 
periods may improve baseline accuracy. 
Summary 
Vascular reactivity in arterialized capillaries is, at least in part, impaired by 
smooth muscle cells, which are presumably immature. This immaturity may lead to 
dysfunction because the smooth muscle cells are not yet fully-aligned, may not yet 
contain normal levels of actin and myosin, or may express lower levels of vasoactive 
receptors. By understanding the mechanisms behind the impairment, we may be able to 
minimize the duration and extent of the impairment to more quickly and effectively 
increase perfusion to downstream tissues. An extrapolated application of this could 
potentially be to induce or quicken the development of new collateral vessels. 
Manipulating the arterialization of capillaries may improve PAOD patient prognosis by 
more quickly and appropriately providing and improving blood flow to ischemic tissues 
downstream of an occlusion. 
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